You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 84 No. 3, September 1961 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (23)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Nature and Incidence of Photosensitivity Reactions to Demethylchlortetracycline

MILTON M. CAHN, M.D.; EDWIN J. LEVY, M.D.; JOHN A. McMILLEN, M.D.

Arch Dermatol. 1961;84(3):485-489.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Several recent case reports1-3 have indicated the occurrence of photosensitivity reactions in patients taking demethylchlortetracycline.* This study was undertaken to determine the incidence of such reactions, the relationship between their occurrence and dosage of the drug, the responsible spectral range, and the nature of these reactions, whether photoallergic or phototoxic.4

Method

I. Determination of Incidence of Demethylchlortetracycline Photosensitivity Reactions.—

(A) Using Artificial Light Sources: One hundred white men, who had not been exposed to sunlight for the preceding 6 months were included in this phase of the study. The minimal erythema dose (M.E.D.), which is defined as that amount of ultraviolet light required to produce a barely perceptable erythema on the skin 24 hours after exposure (1+) was determined for each subject. This was accomplished by giving graded exposures of ultraviolet light to skin test sites on the upper back, as emitted by a Westinghouse fluorescent . . . [Full Text PDF of this Article]


Author Affiliations

PHILADELPHIA; PEARL RIVER, N. Y.

From the Department of Dermatology, School of Medicine, University of Pennsylvania (Dr. Cahn and Dr. Levy), and Lederle Laboratories, Research Division (Dr. McMillen).

Declomycin, Lederle Laboratories, Pearl River, N.Y.


Footnotes

Submitted for publication May 1, 1961.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1961 American Medical Association. All Rights Reserved.